Mark I Rosenblatt, MD, PhD, MBA, MHA
UIC Distinguished Professor
G. Stephen Irwin Executive Dean, University of Illinois College of Medicine
Interim Chief Executive Officer, University of Illinois Hospital & Clinics
Associate Vice Chancellor for Physician Affairs, UI Health
Director, Corneal Regenerative Medicine Laboratory
Department of Ophthalmology and Visual Sciences
Related Sites:
About
Mark I. Rosenblatt, MD, PhD, MBA, MHA has been the Executive Dean of the University of Illinois College of Medicine since 2019. He has also served as Associate Vice Chancellor for Physician Affairs since 2022 and as Interim CEO of the University Hospital & Clinics since September 2023. He was appointed as the G. Stephen Irwin Executive Dean and as UIC Distinguished Professor in 2023.
Prior to becoming Executive Dean, Dr. Rosenblatt was appointed in 2014 as Illinois Lions/Charles I. Young Chair, Professor, and Head of the Department of Ophthalmology and Visual Sciences at the University of Illinois College of Medicine. In addition, he served as Director of the Medical Scientist Training Program from 2019 to 2022. From 2008 to 2014, Dr. Rosenblatt was a faculty member at Weill Cornell Medical College, including a term as Vice Chair of Ophthalmology.
Dr. Rosenblatt is an internationally recognized clinician-scientist. As Director of the Corneal Regenerative Medicine Laboratory, he leads groups of scientists investigating the mechanism of corneal peripheral nerve regeneration following injury, and the use of nanoengineered biomaterials for use in stem cell delivery to the ocular surface. His work in regenerative medicine has been funded by the National Institutes of Health, the Department of Defense, Research to Prevent Blindness, the Falk Family Foundation, and the Tri-Institutional Stem Cell Initiative. Dr. Rosenblatt has published widely, including over 150 original manuscripts, review articles, book chapters, and abstracts.
Dr. Rosenblatt is a graduate of the University of Miami Miller School of Medicine’s Honors Program in Medical Education and the Combined MD/PhD program, receiving his PhD in Biochemistry, Cell, and Molecular Biology. He also completed his MBA at New York University and his MHA at the University of Illinois Chicago. Dr. Rosenblatt completed his ophthalmology residency and combined clinical/research fellowship in corneal disease at the Massachusetts Eye and Ear Infirmary/Harvard Medical School. He is a member of the Alpha Omega Alpha and Omicron Delta Kappa honor societies.
Publication Aggregators
Notable Honors
2014, Achievement Award, American Academy of Ophthalmology
2009-2013, Career Development Award, Research to Prevent Blindness
2005, Resident/Research Fellow Award, AUPO/Research to Prevent Blindness
2003-2005, Joint Clinical Research Center Fellowship, Massachusetts Eye and Ear Infirmary and Schepens Eye Research Institute
Education
MD: University of Miami School of Medicine
PhD in Biochemistry, Cell, and Molecular Biology: University of Miami School of Medicine
Residency in Ophthalmology: Massachusetts Eye and Ear Infirmary, Harvard Medical School
Research Fellowship: Schepens Eye Research Institute, Harvard Medical School
Clinical Fellowship in Cornea and External Disease: Massachusetts Eye and Ear Infirmary
MBA: New York University Stern School of Business
MHA: University of Illinois Chicago